Correlation Between Cogent Communications and Takeda Pharmaceutical
Can any of the company-specific risk be diversified away by investing in both Cogent Communications and Takeda Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cogent Communications and Takeda Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cogent Communications Holdings and Takeda Pharmaceutical, you can compare the effects of market volatilities on Cogent Communications and Takeda Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cogent Communications with a short position of Takeda Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cogent Communications and Takeda Pharmaceutical.
Diversification Opportunities for Cogent Communications and Takeda Pharmaceutical
-0.83 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Cogent and Takeda is -0.83. Overlapping area represents the amount of risk that can be diversified away by holding Cogent Communications Holdings and Takeda Pharmaceutical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Takeda Pharmaceutical and Cogent Communications is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cogent Communications Holdings are associated (or correlated) with Takeda Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Takeda Pharmaceutical has no effect on the direction of Cogent Communications i.e., Cogent Communications and Takeda Pharmaceutical go up and down completely randomly.
Pair Corralation between Cogent Communications and Takeda Pharmaceutical
Assuming the 90 days trading horizon Cogent Communications Holdings is expected to generate 2.64 times more return on investment than Takeda Pharmaceutical. However, Cogent Communications is 2.64 times more volatile than Takeda Pharmaceutical. It trades about 0.11 of its potential returns per unit of risk. Takeda Pharmaceutical is currently generating about 0.05 per unit of risk. If you would invest 7,357 in Cogent Communications Holdings on September 3, 2024 and sell it today you would earn a total of 343.00 from holding Cogent Communications Holdings or generate 4.66% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cogent Communications Holdings vs. Takeda Pharmaceutical
Performance |
| Timeline |
| Cogent Communications |
| Takeda Pharmaceutical |
Cogent Communications and Takeda Pharmaceutical Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cogent Communications and Takeda Pharmaceutical
The main advantage of trading using opposite Cogent Communications and Takeda Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cogent Communications position performs unexpectedly, Takeda Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Takeda Pharmaceutical will offset losses from the drop in Takeda Pharmaceutical's long position.| Cogent Communications vs. T Mobile | Cogent Communications vs. China Mobile Limited | Cogent Communications vs. ATT Inc | Cogent Communications vs. Nippon Telegraph and |
| Takeda Pharmaceutical vs. Apple Inc | Takeda Pharmaceutical vs. Apple Inc | Takeda Pharmaceutical vs. Apple Inc | Takeda Pharmaceutical vs. Apple Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Complementary Tools
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |